Parexel has introduced a new ecosystem of integrated data-driven services as the industry looks to gain better insights from myriad information sources.
The EMA says aligning antibiotic trial requirements with the US FDA and Japan’s PMDA should allow drug firms to conduct single global development programmes.
Drug manufacturers selling insulin in Nevada in the US must disclose what they charge and how much the make from the drug under legislation signed into law last week.
Pfizer has recalled four injectables – including the already scarce heart surgery drug Sodium Bicarbonate - made at Hospira's facility in Rocky Mount, North Carolina after identifying a potential contamination risk.
Researchers define action profile of Bial compound
Experts are calling for an increased focus on human cellular model development after animal tests failed to detect the toxicity of an experimental drug before the first-in-human clinical trial that left one dead.
LabCorp’s Covance has opened a new companion diagnostics laboratory as is prepares for an increasing demand for precision medicine – a market expected to reach $112.62bn by 2025.
The European Commission has confirmed that UK drug ingredient manufacturers will have to supply European customers with written confirmation their products are made in compliance with EU standards after Brexit.
Inovio Pharmaceuticals has started Phase III trials of its DNA-based human papillomavirus therapy VGX-3100 after the US FDA lifted a clinical hold imposed list year.
European regulators’ efforts to develop continuous manufacturing guidelines are not as advanced as their US counterparts according to delegates who attended a conference last month.
At least 50,000 volunteers are needed to participate in clinical trials for Alzheimer’s disease – the global cost of which is expected to reach $2 trillion by 2030.
The global central laboratory and support services provider has secured a $24.5m Series A investment and is on track to double in size, again, over the next five years, says CEO.
In the first public application of its technology, Bitmark Inc. has partnered with the UC Berkeley School of Public Health to conduct studies using its blockchain technology.
Topstone Research has joined the Partner Program at Medrio, a Software as a Service (SaaS) company that provides electronic data capture (EDC) and eSource to clinical trials.
Regulators in Europe, Japan and the US say they have aligned clinical data requirements for new antibiotics to encourage industry to develop drugs for infections caused by resistant bacteria.
Pharmaceuticals should be at the heart of Brexit talks says the Association of the British Pharmaceutical Industry, which has pledged to work with the UK’s minority Government.
Cure Pharmaceutical has entered into a strategic collaboration to test and develop potential cancer therapeutics utilising a blend of the cannabis plant-derived terpenes.
Bristol Myers Squibb (B-MS) has recalled one lot of the oral anti-clotting drug Eliquis in the US after a customer found 2.5mg strength tablets in a bottle labelled as containing 5mg tablets.
Forty mice were launched into space last week aboard the SpaceX Dragon, which will deliver the genetically engineered research models to the International Space Station for study in microgravity.
The international contract research organization (CRO) and non-profit organization have signed a three-year “teaming agreement” to advance clinical trials for gynecologic malignancies.
Pop Test Abuse Deterrent Technologies has received a patent for an opioid drug delivery and abuse deterrent ‘smart pill’ it says can prevent death, theft, diversion and counterfeiting.
Chesapeake IRB has announced back-to-back acquisitions of two independent institutional review boards (IRBs) as the company aims to expand its services.
Teams of engineers at CordenPharma and Acasti Pharma came together to develop a proprietary continuous manufacturing process – which simplifies scale up and process re-validation.
Rich Pharmaceuticals has selected a clinical trial site in Thailand at which it will conduct a Phase I/II trial in collaboration with the contract research organization (CRO) CMIC ASIA-PACIFIC, PTE. LTD. (CMIC).
Continuous manufacturing equipment installed at a CordenPharma French facility has reduced cycle time and cost of making a hypertriglyceridemia drug, says Acasti Pharma.